Clinical Trial Update: Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with first-line chemotherapy in patients aged 75 and older with metastatic colorectal adenocarcinoma has completed enrollme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Metastatic Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED